Full metadata record
DC FieldValueLanguage
dc.contributor.authorLiu, TYen_US
dc.contributor.authorChen, SYen_US
dc.contributor.authorLiu, DMen_US
dc.contributor.authorLiou, SCen_US
dc.date.accessioned2014-12-08T15:18:22Z-
dc.date.available2014-12-08T15:18:22Z-
dc.date.issued2005-09-20en_US
dc.identifier.issn0168-3659en_US
dc.identifier.urihttp://dx.doi.org/10.1016/j.jconrel.2005.05.025en_US
dc.identifier.urihttp://hdl.handle.net/11536/13259-
dc.description.abstractCalcium-deficient hydroxyapatite (CDHA) nano-crystals incorporated with bovine serum albumin (BSA) to form BSA-loaded nano-carriers were synthesized via both in-situ and ex-situ processes. Amount of BSA uptake by the CDHA nanocrystals and subsequent release behaviors of the BSA-loaded nano-carriers were investigated. The amount of BSA uptake by CDHA decreases with increasing pH but a larger amount was observed in the ex-situ compared to in-situ process above pH = 8.0. The release profile showed a bursting behavior for the nano-carrier prepared via the ex-situ process, which is probably due to the desorption of BSA molecules. In contrast, for the sample synthesized via the in-situ process at a higher pH level, a slower release profile without bursting behavior due to the dissolution of the BSA-incorporated CDHA crystal is seen from high solution TEM that indicates different extent of interaction between BSA and CDHA. On the other hand, for the nano-carriers prepared via the same process at lower pH level, a two-stage release profile was detected. An initial bursting release is due to the desorption of BSA from the CDHA surface, followed by a slow release as a result of the dissolution of the BSA-incorporated nano-crystals along its c-axis direction. (c) 2005 Elsevier B.V. All rights reserved.en_US
dc.language.isoen_USen_US
dc.subjectnano-carrieren_US
dc.subjectaspect ratioen_US
dc.subjectin-situ processen_US
dc.subjectcalcium-deficient hydroxyapatiteen_US
dc.subjectBSAen_US
dc.subjectrelease behaviorsen_US
dc.titleOn the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug deliveryen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.jconrel.2005.05.025en_US
dc.identifier.journalJOURNAL OF CONTROLLED RELEASEen_US
dc.citation.volume107en_US
dc.citation.issue1en_US
dc.citation.spage112en_US
dc.citation.epage121en_US
dc.contributor.department材料科學與工程學系zh_TW
dc.contributor.departmentDepartment of Materials Science and Engineeringen_US
dc.identifier.wosnumberWOS:000232349300009-
dc.citation.woscount85-
Appears in Collections:Articles


Files in This Item:

  1. 000232349300009.pdf

If it is a zip file, please download the file and unzip it, then open index.html in a browser to view the full text content.